Comorbidities | Acute myeloid leukemia | 3 |
multiple myeloma | 2 | |
malignant lymphoma | 2 | |
acute lymphoid leukemia | 1 | |
myelodysplastic syndrome | 1 | |
aplastic anemia | 1 | |
chemotheapy | induction therapy | 6 |
conditioning regimen hematopoietic stem cell transplantation | 3 | |
consolidation therapy | 1 | |
Nadir WBC count during the chemotherapy | 0–100/μL | 9 |
101–500/μL | 1 | |
501- /μL | 0 | |
focus of infectiona | primary bacteremia | 9 |
severe pneumonia | 1 | |
skin & soft tissue infection | 1 | |
pathogens identified in blood cultures | ||
Gram negatives | 6 | |
K.pneumoniae | 3 | |
E.coli | 1 | |
E.aerogenes | 1 | |
B.fragilis | 1 | |
Gram positives | 5 | |
S.epidermidis | 1 | |
S.hominis | 1 | |
B.cereus | 1 | |
Bacillus sp. | 1 | |
E.gallinarum | 1 | |
days of the infection onsetb | 11.9 [3–18] | |
average number of the samples examined for presepsin | 6.5 [4–9] |